Abstract
e13068Background: In a phase I study we have shown, that a combination of 13-cis retinoic acid (RA) and interleukin-2 (IL-2) was feasible and was able to improve the immune function of cancer patie...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
